Clinical Trials Sponsored by 4-H

Total 1474 results

Azienda USL 4 Prato

Completed

Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients (GIVE)

Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Gastrointestinal Cancer

Italy
Wuxi No. 4 People's Hospital

Unknown

Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

Carcinoma, Bronchogenic | Lymphoma, Malignant | Breast Carcinoma | Cancer of Head and Neck | Soft Tissue Neoplasms | Tumors

China
Guiyang No.4 People's Hospital

Unknown

Evaluation of the Correlation Between the Coronary Stenosis Degree With FFRCT and the Grade of Stable Angina Pectoris

Angina Pectoris | Coronary Stenosis
Azienda Sanitaria Locale 4, Teramo

Unknown

New Methods of Distribution of a Self Sampler Kit for Cervical Cancer Screening (NMDSS2)

Cervical Cancer Cin Grade

Italy
Wuxi No. 4 People's Hospital

Not yet recruiting

Safety Study of 89Zr-NY001 PET Imaging in Patients

Solid Tumor, Adult

China
Wuxi No. 4 People's Hospital

Completed

18F-FDG PET/CT in the Diagnosis of Tuberculous Pericarditis

Diagnostic Self Evaluation
Ningbo Municipal No.4 Hospital

Completed

Abdomen CT and Open Appendicectomy：New Diagnostic and Surgical Procedures (ACAOA)

Wound Infection | Scar | Complication
Azienda Sanitaria Locale 4, Teramo

Unknown

Evaluation of the Efficacy and Tolerability of Etoricoxib Monotherapy Versus Combination Oxycodone-etoricoxib in Moderate to Severe Pain From Chronic Low Back Pain

Low Back Pain

Italy
ENDOPLY
Just 4 Device s.r.o.

Not yet recruiting

ENDOPLY System in Humans: a Pilot Study

Obesity

Czechia
Wuxi No. 4 People's Hospital

Not yet recruiting

Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors

Solid Tumor, Adult

China
Wuxi No. 4 People's Hospital

Unknown

89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors

Solid Tumor, Adult

China
Wuxi No. 4 People's Hospital

Unknown

Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics

Breast Neoplasms | Prostatic Neoplasms
Ningbo Municipal No.4 Hospital

Unknown

High Concentration of Sugar Solution Irrigation Promotes the Healing of Infected Wound

Wound Infection | Sugar Solution
Centro Cardiopatici Toscani
Azienda USL 4 Prato

Recruiting

Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome (PRATO-ACS)

Acute Coronary Syndrome

Italy
Northwestern University
University of Utah; Pastors 4 PCOR

Not yet recruiting

Community Intervention to Reduce CardiovascuLar Disease in Chicago (CIRCL-Chicago)

Hypertension

United States
Assistance Publique - Hôpitaux de Paris
VR 4 GOOD

Recruiting

Use of VIrtual REAlity to Reduce Postoperative Anxiety and Pain After Surgery for Colorectal Cancer (VIREA)

Pain, Postoperative | Colon Tumor, Malignant | Rectum Tumor

France
M.D. Anderson Cancer Center
Cancer Cures 4 Kids

Recruiting

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Angiosarcoma

United States
Independent Public Clinical Hospital No. 4 in Lublin

Recruiting

The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms (COV-PREVENT)

COVID-19 | SARS-CoV-2

Poland
Mary H. Teng

Completed

Sensory Motor Lateralization as Handwriting Intervention in School-Based OT (SML)

Developmental Dysgraphia
H-CYTE

Completed

Autologous Cellular Therapy With PRP-PC in Chronic Lung Diseases: An Observational Study LI-004 (PRP-PC)

COPD ILD

United States
Institute of Cell Therapy
Kyiv City Clinical Hospital # 4

Unknown

Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs

COVID-19 Pneumonia

Ukraine
Azienda USL 4 Prato
Università degli Studi di Brescia

Terminated

Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer (CTXMAB+RT)

Head and Neck Neoplasms | Pharyngeal Neoplasms | Mouth Neoplasms | Laryngeal Neoplasms

Italy
Regione Veneto
European Commission; Azienda ULSS 4 Alto Vicentino

Completed

Life-Long Monitoring of Diabetes Mellitus in Veneto Region

Diabetes Mellitus, Type 2

Italy
H. Lundbeck A/S

Recruiting

Study of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia

United Kingdom
H. Lundbeck A/S

Recruiting

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine (REJOIN)

Migraine

Spain, Italy, Serbia, United States, Argentina, Mexico, Canada, United Kingdom, Portugal
H. Lundbeck A/S

Active, not recruiting

A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults

Healthy Participants

China
H. Lundbeck A/S

Active, not recruiting

A Trial Investigating Lu AF28996 in Healthy Adult Participants

Healthy Participants

United States
H. Lundbeck A/S

Completed

Observational Study in Multiple System Atrophy (TALISMAN)

Multiple System Atrophy

China
H. Lundbeck A/S

Completed

Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions

Healthy

China
H. Lundbeck A/S

Active, not recruiting

A Study of Lu AF82422 in Participants With Multiple System Atrophy (AMULET)

Multiple System Atrophy

United States, Japan
H. Lundbeck A/S

Completed

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)

Parkinson Disease

Japan
H. Lundbeck A/S

Completed

Eptinezumab in Participants With Episodic Cluster Headache (ALLEVIATE)

Cluster Headache, Episodic

Spain, United States, Germany, Portugal, Italy, Netherlands, Finland, Belgium, Czechia, Denmark, France, Georgia, Russian Federation, United Kingdom, Greece, Estonia, Japan, Norway, Sweden
H. Lundbeck A/S

Completed

A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments (DELIVER)

Migraine

Spain, United States, Bulgaria, Hungary, Germany, Poland, Georgia, Belgium, Finland, Czechia, Denmark, France, Italy, Russian Federation, Slovakia, Sweden, United Kingdom
H. Lundbeck A/S

Completed

Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease

Healthy | Alzheimer Disease

United States
H. Lundbeck A/S

Completed

A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) (CHRONICLE)

Chronic Cluster Headache

Spain, Germany, United Kingdom, United States, Netherlands, Denmark, Finland, France, Italy
H. Lundbeck A/S

Completed

Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)

PTSD

United States
H. Lundbeck A/S

Completed

Safety and Tolerability of Lu AG06474 in Healthy Young Men

Healthy

United States
H. Lundbeck A/S

Terminated

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

Depressive Disorder, Major

United States, Korea, Republic of, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Latvia, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Mexico, South Africa, United Kingdom
H. Lundbeck A/S

Completed

A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines

Healthy Participants

United States
H. Lundbeck A/S

Completed

A Study Investigating Lu AG06466 in Healthy Men

Healthy Volunteers

United Kingdom
H. Lundbeck A/S

Completed

A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects

Healthy

Denmark
H. Lundbeck A/S

Completed

Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease

Healthy | Parkinson Disease

United States
H. Lundbeck A/S

Completed

Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) (RECONNECT)

Anxiety Disorders | MDD

Estonia, France, Italy, Korea, Republic of, Poland, Spain
H. Lundbeck A/S

Completed

Binding of Lu AG06466 in the Brain in Healthy Men

Healthy

Belgium
H. Lundbeck A/S

Completed

An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients

Parkinson Disease

United States
H. Lundbeck A/S

Completed

Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia (Debut)

Schizophrenia

Estonia, Mexico, Russian Federation, Serbia, Ukraine, United States, Bulgaria, Canada, Czechia, Poland, Slovakia, Spain, Romania
H. Lundbeck A/S

Terminated

Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia

Schizophrenia

Bulgaria, Czechia, Estonia, Germany, Hungary, Latvia, Poland, Ukraine
H. Lundbeck A/S

Terminated

Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects

Healthy | Parkinson Disease

France
H. Lundbeck A/S

Completed

Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700

Schizophrenia

United States
H. Lundbeck A/S

Terminated

Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia (Anew)

Treatment-resistant Schizophrenia

United States, Japan, Russian Federation, Bulgaria, United Kingdom

Clinical Trials Sponsored by 4-H

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations